ImmunityBio share price logo

ImmunityBio

NASDAQ: IBRX

Large Cap

$10.51

+0.60

(+6.05%)

as on

ImmunityBio Stock Performance

as on October 10, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $9.87
    $10.80
    downward going graph

    6.09%

    Downside

    2.76%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.95
    $12.43
    downward going graph

    81.45%

    Downside

    18.27%

    Upside

    downward going graph

ImmunityBio share price movements today

Previous Close
$9.91
Open
$10.00
Volume
20.2M
Market Cap
$10.5B
Day's Low - High
$9.87 - $10.80
52 Week Low - High
$1.95 - $12.43

ImmunityBio Historical Returns

1 Month Return
+ 36.14 %
3 Month Return
+ 27.86 %
1 Year Return
+ 345.34 %
3 Year Return
+ 634.97 %
5 Year Return
+ 19.3 %

ImmunityBio Stock Fundamentals & Key Indicators

Check ImmunityBio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.5B

EPS (TTM)

-0.9736

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.18

Industry PE ratio

7.28

PEG Ratio

0.08

EBITDA

-892.7M

Revenue (TTM)

165.8M

Profit Margin

94.63%

Return On Equity TTM

134.99%

ImmunityBio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ImmunityBio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ImmunityBio image
ImmunityBio
StrongBuy$10.5B19.30%-10.1894.63%0.00%
Moderna image
Moderna
Neutral$78.6B-26.21%-24.69-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$127.6B185.06%29.0686.04%0.00%
Regeneron image
Regeneron
Buy$76.4B35.73%17.6684.86%0.50%

Stock Returns calculator for ImmunityBio Stock including INR - Dollar returns

The ImmunityBio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ImmunityBio investment value today

Current value as on today

₹4,85,594

Returns

₹3,85,594

(+385.59%)

Returns from ImmunityBio Stock

₹3,45,339 (+345.34%)

Dollar Impact

₹40,255 (+40.26%)

Analyst Recommendation on ImmunityBio Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for ImmunityBio. Average target price of $12.75

ImmunityBio Share Price Target

Get share price movements and forecasts by analysts on ImmunityBio.

What analysts predicted

17.57%UPSIDE

Target Price

$12.75

Current Price

$10.51

Analyzed by

3 Analysts

High

$15

Target

$12.75

Low

$12

ImmunityBio target price $12.75, a slight upside of 17.57% compared to current price of $10.51. According to 3 analysts rating.

Indian Investors' Interest in ImmunityBio Stock

Investment in ImmunityBio Shares on INDmoney has grown by 257.28% in the last 30 days, indicating increased investment activity.

Time period: to

Change:257.28% versus previous 30 day period

Search interest for ImmunityBio Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

ImmunityBio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
1
6
7
16
26
32
38
44
51
Gross Profit
0
1
6
7
16
26
27
34
43
50
Operating Income
-95
-99
-80
-69
-64
-71
-55
-64
-69
-61
EBITDA
-97
-91
-41
-40
-97
-59
-35
-31
-599
-225
Interest Expense
37
39
40
14
28
28
27
27
28
0
Depreciation
4
4
4
4
3
3
3
3
4
4
Income Before Tax
-134
-134
-85
-59
-129
-92
-67
-62
-632
-230
Income Tax Expense
-
-
-
-
0
0
0
0
0
-
Net Income
-134
-134
-85
-59
-129
-92
-67
-61
-632
-230
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
99.65%
99.49%
87.12%
88.91%
99.46%
99.42%

ImmunityBio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
0
14
113
Gross Profit
0
3
-8
0
0
0
0
14
112
Operating Income
-99
-98
-66
-220
-330
-351
-362
-344
-256
EBITDA
-90
-86
-51
-204
-320
-351
-478
-264
-223
Interest Expense
0
0
5
9
14
47
86
131
112
Depreciation
5
9
14
12
14
18
18
17
15
Income Before Tax
-96
-96
-65
-226
-349
-417
-583
-413
-351
Income Tax Expense
0
0
0
-1
0
0
0
-
0
Net Income
-96
-96
-65
-221
-346
-416
-583
-413
-351
Net Profit Margin
100.00%
6717.02%
-20858.14%
100.00%
100.00%
100.00%
100.00%
100.00%
99.34%

ImmunityBio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-134
-134
-85
-59
-129
-92
-67
-61
-632
-230
Operating Cash Flow
-106
-100
-98
-85
-85
-79
-68
-70
-75
-66
Investing Cash Flow
-35
-51
65
9
4
-16
-181
43
-31
-107
Financing Cash Flow
10
148
15
106
0
172
173
54
223
44
Change in Cash
-132
-2
-18
31
-82
76
-76
28
116
-129

ImmunityBio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-96
-96
-160
-224
-346
-416
-583
-413
-351
Operating Cash Flow
-48
-63
-152
-171
-274
-337
-366
-391
-304
Investing Cash Flow
99
57
18
-19
-84
27
-30
-12
-149
Financing Cash Flow
-34
0
114
150
505
233
558
281
400
Change in Cash
15
-7
-19
-40
146
-76
160
-121
-54

Global Institutional Holdings in ImmunityBio

Check out the Institutions with significant holdings in ImmunityBio.

Funds
Holdings
Vanguard
3.13%
VANGUARD INDEX FUNDS
2.61%
iShares
2.07%
SPDR
1.27%
Schwab
0.34%
See all

ImmunityBio News & Key Events

  • img

    Today's Timeline - 30 September

    Wed, 08:08 AM

    -

    IBRX broke above $9.44, extending its September rally and on track for its strongest monthly gain since February.

    Wed, 10:07 PM

    -

    ImmunityBio's stock closed at $8.83, up 11.07% over the month and 256.05% over the past year.

Insights on ImmunityBio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IBRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IBRX stock has moved up by 345.3%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -632.78M → -230.37M (in $), with an average increase of 174.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 10 quarters, 40.0K → 51.23M (in $), with an average increase of 39.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 393.3%

About ImmunityBio

ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
OrganisationImmunityBio
Headquarters3530 John Hopkins Court, San Diego, CA, 92121, US
IndustryBiotechnology
CEORichard Gerald Adcock

Key Management of ImmunityBio

Name

Title

Dr. Sandeep K. Reddy M.D.

Chief Medical Officer

Mr. Richard Gerald Adcock

President, CEO & Director

Mr. David C. Sachs

Chief Financial Officer

Dr. Barry J. Simon M.D.

Chief Corporate Affairs Officer & Director

Dr. Enrique Diloné Ph.D., RAC

Chief Technology Officer

Ms. Emily Arison

Senior Vice President of Human Resources

Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc.

Founder, Executive Chairman and Global Chief Scientific & Medical Officer

Ms. Regan J. Lauer

Chief Accounting Officer

Ms. Sarah Singleton

Chief Communications Officer & Head of Patient Advocacy

Dr. Leonard S. Sender M.D.

Chief Medical Officer of Liquid Tumors & Cell Therapy

FAQs

What is ImmunityBio share price today?

ImmunityBio share price today is $10.51 as on at the close of the market. ImmunityBio share today touched a day high of $10.80 and a low of $9.87.

What is the 52 week high and 52 week low for ImmunityBio share?

ImmunityBio share touched a 52 week high of $12.43 on and a 52 week low of $1.95 on . ImmunityBio stock price today i.e. is closed at $10.51,which is 15.45% down from its 52 week high and 438.97% up from its 52 week low.

What is ImmunityBio's market capitalisation today?

ImmunityBio market capitalisation is $0.01T as on .

How to invest in ImmunityBio Stock (IBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ImmunityBio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ImmunityBio Stock (IBRX) from India?

Indian investors can start investing in ImmunityBio (IBRX) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in ImmunityBio stock (as per the Rupee-Dollar exchange rate as on ). Based on ImmunityBio share’s latest price of $10.51 as on October 10, 2026 at 8:46 am IST, you will get 0.9515 shares of ImmunityBio. Learn more about fractional shares .

What are the returns that ImmunityBio has given to Indian investors in the last 5 years?

ImmunityBio stock has given 19.3% share price returns and 28.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?